Tuberculous Enterocolitis: Prevalence and Factors of Hospital Lethality in Moscow
https://doi.org/10.58838/2075-1230-2025-103-5-44-51
Abstract
The objective: to assess the incidence of tuberculous enterocolitis (TEC) in Moscow from 2016 to 2023 and determine main factors of hospital lethality of this form of extrapulmonary tuberculosis.
Subjects and Methods. Sources of information on tuberculous enterocolitis patients were as follows: Form 003/u on Hospital Record of new patients with tuberculous enterocolitis from 2016 to 2023 who were treated at Clinic 2 of Moscow Research and Clinical Center for Tuberculosis Control; Form no. 8 on Information on Active Tuberculosis Cases in Moscow for the same period.
Results. As statistically calculated, in Moscow the estimated incidence of tuberculous enterocolitis makes 0.2 cases per 100,000 population, accounting for 1.0% of all new tuberculosis. Hospital lethality for all forms of tuberculosis was recorded at 27.65%, and the main predictors were the following: young age, positive HIV status, surgical complications, caseous pneumonia and tuberculous meningitis, as well as multidrug resistance. The resulting mathematical model for predicting a fatal outcome is a convenient tool for determining therapeutic tactics in tuberculous enterocolitis and routing patients.
About the Authors
M. N. ReshetnikovRussian Federation
Mikhail N. Reshetnikov - Candidate of Medical Sciences, Surgeon of Surgery Tuberculosis Department no. 2, Clinic no. 2, Leading Researcher of Research Clinical Department, Associate Professor of Phthisiology Department, Russian Medical Academy of On-going Professional Education, Russian Ministry of Health.
10 Stromynka St., Moscow, 107014
Phone: + 7 (499) 268-00-05
D. V. Plotkin
Russian Federation
Dmitry V. Plotkin - Doctor of Medical Sciences, Associate Professor, Surgeon of Surgery Tuberculosis Department no. 2, Clinic no. 2, Leading Researcher of Research Clinical Department, Professor of General Surgery Department named after V.M. Buyanov, Surgery Institute, Pirogov Russian National Research Medical University, Russian Ministry of Health.
10 Stromynka St., Moscow, 107014
Phone: + 7 (499) 268-00-05
S. A. Sterlikov
Russian Federation
Sergey A. Sterlikov - Doctor of Medical Sciences, Chief Researcher.
11 Dobrolyubova St., Moscow, 127254
Phone: +7 (495) 618-31-83
P. A. Braviy
Russian Federation
Pavel A. Braviy - Endoscopist of Endoscopy Department no. 2, Clinic no. 2.
10 Stromynka St., Moscow, 107014
Phone: + 7 (499) 268-00-05
O. N. Zuban
Russian Federation
Oleg N. Zuban - Doctor of Medical Sciences, Professor, Deputy Director for Research and Clinical Activities, Professor of Phthisiology Department, Russian Medical Academy of On-going Professional Education, Russian Ministry of Health.
10 Stromynka St., Moscow, 107014
Phone: + 7 (499) 268-00-05
E. M. Bogorodskaya
Russian Federation
Elena M. Bogorodskaya - Doctor of Medical Sciences, Professor, Head of Phthisiology Department.
2/1 Build. 1. Barrikadnaya St., Moscow, 125993
Phone: +7 (495) 680-05-99
References
1. Belilovsky E.M., Borisov S.E. Organization of epidemiological tuberculosis surveillance in the city of Moscow. Problemy Sotsialnoy Gigieny, Zdravookhraneniya i Istorii Meditsiny, 2021, vol. 29, no. S2, pp. 1275-1280. (In Russ.) https://doi.org/10.32687/0869-866X-2021-29-s2-1275-1280
2. Bogorodskaya E.M., Slogotskaya L.V., Shamuratova L.F., Sevostyanova T.A. Screening for tuberculosis infection in children and adolescents by two intracutaneous tests: with tuberculin and tuberculosis recombinant allergen (ESAT-6/CFP-10) in Moscow in 2021. Tuberculosis and Lung Diseases, 2022, vol. 100, no. 11, pp. 29-38. (In Russ.) https://doi.org/10.21292/2075-1230-2022-100-11-29-38
3. Vostroknutov M.E., Dyuzheva E.V., Kuznetsova A.V., Senko O.V. Risk factors of hospital mortality in patients with TB/HIV co-infection confined in the penitentiary system. Tuberculosis and Lung Diseases, 2019, vol. 97, no. 7, pp. 34-41. (In Russ.) https://doi.org/10.21292/2075-1230-2019-97-7-34-41
4. Kulchavenya E.V., Zhukova I.I. Extrapulmonary tuberculosis – more questions than answers. Tuberculosis and Lung Diseases, 2017, vol. 95, no. 2, pp. 59-63. (In Russ.) https://doi.org/10.21292/2075-1230-2017-95-2-59-63
5. Panteleev A.M. Clinical understanding of pathogenesis of tuberculosis generalization in HIV patients. Tuberculosis and Lung Diseases, 2015, vol. 93, no. 2, pp. 26-31. (In Russ.) https://doi.org/10.21292/2075-1230-2015-0-2-26-31
6. Plotkin D.V., Sinitsyn M.V., Reshetnikov M.N., Sterlikov S.A., Bogorodskaya E.M. Tuberculous peritonitis: epidemiological, gender- and age-based characteristics in the city of Moscow. Tuberculosis and Lung Diseases, 2023, vol. 101, no. 2, pp. 54-63. (In Russ.) http://doi.org/10.58838/2075-1230-2023-101-2-54-63
7. Saenko S.S., Sterlikov S.A., Rusakova L.I., Lekhleyder M.V., Pirogova N.D., Surnacheva I.F., Gudenkov M.A., Svicharskaya A.K., Podgaynaya O.A., Kononenko Yu.S., Novikova T.V., Yukhnova E.A., Frolov E.G., Gromov A.V., Gaevaya I.S. Predictors of unfavorable outcomes of tuberculosis cases treated with chemotherapy regimens I, II, III. Vestnik TSNIIT, 2020, vol. 12, no. 3, pp. 24-34. (In Russ.) https://doi.org/10.7868/S2587667820030048
8. Al-Zanbagi A.B., Shariff M.K. Gastrointestinal tuberculosis: A systematic review of epidemiology, presentation, diagnosis and treatment. Saudi J. Gastroenterol., 2021, vol. 27, no. 5, pp. 261-274. https://doi.org/10.4103/sjg.sjg_148_21
9. Arega B., Mersha A., Minda A., Getachew Y., Sitotaw A., Gebeyehu T., Agunie A. Epidemiology and the diagnostic challenge of extra-pulmonary tuberculosis in a teaching hospital in Ethiopia. PLoS One, 2020, vol. 15, no. 12, pp. e0243945. https://doi.org/10.1371/journal.pone.0243945
10. Chakinala R.C., Khatri A.M. Gastrointestinal Tuberculosis. In: StatPearls. Treasure Island (FL), StatPearls Publ., 2024 Jan. Available: https://www.ncbi.nlm.nih.gov/books/NBK556115/ Accessed July 31, 2024
11. Chien K., Seemangal J., Batt J., Vozoris N.T. Abdominal tuberculosis: a descriptive case series of the experience in a Canadian tuberculosis clinic. Int. J. Tuberc. Lung Dis., 2018, vol. 22, no. 6, pp. 681-685. https://doi.org/10.5588/ijtld.17.0685
12. Gopalaswamy R., Dusthackeer V.N.A., Kannayan S., Subbian S. Extrapulmonary tuberculosis - an update on the diagnosis, treatment and drug resistance. J. Respir., 2021, vol. 1, no. 2, pp. 141-164. https://doi.org/10.3390/jor1020015
13. Hood G., Trieu L., Ahuja S.D. Mortality among tuberculosis patients in New York City. Int. J. Tuberc. Lung Dis., 2019, vol. 23, no. 2, pp. 252-259. https://doi.org/10.5588/ijtld.18.0305
14. Pang Y., An J., Shu W., Huo F., Chu N., Gao M., Qin S., Huang H., Chen X., Xu S. Epidemiology of extrapulmonary tuberculosis among inpatients, China, 2008-2017. Emerg. Infect. Dis., 2019, vol. 25, no. 3, pp. 457-464. https://doi.org/10.3201/eid2503.180572
15. Peto H.M., Pratt R.H., Harrington T.A., LoBue P.A., Armstrong L.R. Epidemiology of extrapulmonary tuberculosis in the United States, 1993-2006. Clin. Infect. Dis., 2009, vol. 49, no. 9, pp. 1350-1357. https://doi.org/10.1086/605559
16. Sheer T.A., Coyle W.J. Gastrointestinal tuberculosis. Curr. Gastroenterol. Rep., 2003, vol. 5, no. 4, pp. 273-278. https://doi.org/10.1007/s11894-003-0063-1
17. Shivakoti R., Sharma D., Mamoon G., Pham K. Association of HIV infection with extrapulmonary tuberculosis: a systematic review. Infection, 2017, vol. 45, no. 1, pp. 11-21. https://doi.org/10.1007/s15010-016-0960-5
18. Skrahina A., Hurevich H., Zalutskaya A., Sahalchyk E., Astrauko A., Hoffner S., Rusovich V., Dadu A., de Colombani P., Dara M., van Gemert W., Zignol M. Multidrug-resistant tuberculosis in Belarus: the size of the problem and associated risk factors. Bull World Health Organ., 2013, vol. 91, no. 1, pp. 36-45. https://doi.org/10.2471/BLT.12.104588
19. Solovic I., Jonsson J., Korzeniewska-Koseła M., Chiotan D.I., Pace-Asciak A., Slump E., Rumetshofer R., Abubakar I., Kos S., Svetina-Sorli P., Haas W., Bauer T., Sandgren A., van der Werf M.J. Challenges in diagnosing extrapulmonary tuberculosis in the European Union, 2011. Euro Surveill., 2013, vol. 18, no. 12, pp. 20432.
20. Sreeramareddy C.T., Panduru K.V., Verma S.C., Joshi H.S., Bates M.N. Comparison of pulmonary and extrapulmonary tuberculosis in Nepal-a hospital-based retrospective study. BMC Infect. Dis., 2008, no. 8, pp. 1-8. https://doi.org/10.1186/1471-2334-8-8
21. Uygur-Bayramicli O., Dabak G., Dabak R. A clinical dilemma: abdominal tuberculosis. World J. Gastroenterol., 2003, vol. 5, no. 9, pp. 1098-1101. https://doi.org/10.3748/wjg.v9.i5
22. Waitt C.J., Squire S.B. A systematic review of risk factors for death in adults during and after tuberculosis treatment. Int. J. Tuberc. Lung Dis., 2011, vol. 15, no. 7, pp. 871-885. https://doi.org/10.5588/ijtld.10.0352
Review
For citations:
Reshetnikov M.N., Plotkin D.V., Sterlikov S.A., Braviy P.A., Zuban O.N., Bogorodskaya E.M. Tuberculous Enterocolitis: Prevalence and Factors of Hospital Lethality in Moscow. Tuberculosis and Lung Diseases. 2025;103(5):44-51. (In Russ.) https://doi.org/10.58838/2075-1230-2025-103-5-44-51




































